These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36405270)

  • 1. Prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: A systematic review and meta-analysis.
    Wang XY; Chai YM; Huang WH; Zhang Y
    World J Clin Cases; 2022 Nov; 10(32):11812-11826. PubMed ID: 36405270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.
    Franco JV; Jung JH; Imamura M; Borofsky M; Omar MI; Escobar Liquitay CM; Young S; Golzarian J; Veroniki AA; Garegnani L; Dahm P
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013656. PubMed ID: 34693990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Reddy B; Shin TY; Kim MH; Narayan V; Dahm P
    Cochrane Database Syst Rev; 2020 Dec; 12(12):CD012867. PubMed ID: 33368143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of prostate artery embolization on lower urinary tract symptoms related to benign prostatic hyperplasia: a systematic review and meta-analysis.
    Wang XY; Zong HT; Zhang Y
    Clin Interv Aging; 2016; 11():1609-1622. PubMed ID: 27956827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Jung JH; McCutcheon KA; Borofsky M; Young S; Golzarian J; Kim MH; Narayan VM; Dahm P
    Cochrane Database Syst Rev; 2022 Mar; 3(3):CD012867. PubMed ID: 35349161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostatic artery embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia: protocol for a non-inferiority clinical trial.
    Napal Lecumberri S; Insausti Gorbea I; Sáez de Ocáriz García A; Solchaga Álvarez S; Cebrián Lostal JL; Monreal Beortegui R; Giral Villalta PJ; Urtasun Grijalba F
    Res Rep Urol; 2018; 10():17-22. PubMed ID: 29492398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: 2-yr Outcomes of a Randomised, Open-label, Single-centre Trial.
    Abt D; Müllhaupt G; Hechelhammer L; Markart S; Güsewell S; Schmid HP; Mordasini L; Engeler DS
    Eur Urol; 2021 Jul; 80(1):34-42. PubMed ID: 33612376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety Evaluation of Transurethral Resection of the Prostate versus Plasmakinetic Enucleation of the Prostate in the Treatment of Massive Benign Prostatic Hyperplasia.
    Zhang J; Wang Y; Li S; Jin S; Zhang S; Zhao C; Yang W; Cui S; Liu Y
    Urol Int; 2021; 105(9-10):735-742. PubMed ID: 33524981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
    Franco JV; Garegnani L; Escobar Liquitay CM; Borofsky M; Dahm P
    Cochrane Database Syst Rev; 2021 Jun; 6(6):CD004135. PubMed ID: 34180047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Review and Meta-analysis Comparing Prostatic Artery Embolization to Gold-Standard Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia.
    Knight GM; Talwar A; Salem R; Mouli S
    Cardiovasc Intervent Radiol; 2021 Feb; 44(2):183-193. PubMed ID: 33078236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population.
    Wang MQ; Guo LP; Zhang GD; Yuan K; Li K; Duan F; Yan JY; Wang Y; Kang HY; Wang ZJ
    BMC Urol; 2015 Apr; 15():33. PubMed ID: 25887036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study).
    Ray AF; Powell J; Speakman MJ; Longford NT; DasGupta R; Bryant T; Modi S; Dyer J; Harris M; Carolan-Rees G; Hacking N
    BJU Int; 2018 Aug; 122(2):270-282. PubMed ID: 29645352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective observation of the efficacy and safety of prostatic artery embolization combined with transurethral resection of the prostate and simple transurethral resection of the prostate in the treatment of large (> 100 mL) benign prostatic hyperplasia.
    Tang Y; Wang RL; Ruan DD; Chen X; Zhou YF; Wu SJ; Cai SL; Zhang JH; Yang FG; Luo JW; Fang ZT
    Abdom Radiol (NY); 2021 Dec; 46(12):5746-5757. PubMed ID: 34448024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An updated meta-analysis of prostatic arterial embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia.
    Xu XJ; Li J; Huang XZ; Liu Q
    World J Urol; 2020 Oct; 38(10):2455-2468. PubMed ID: 31813027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized Comparison of Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia.
    Insausti I; Sáez de Ocáriz A; Galbete A; Capdevila F; Solchaga S; Giral P; Bilhim T; Isaacson A; Urtasun F; Napal S
    J Vasc Interv Radiol; 2020 Jun; 31(6):882-890. PubMed ID: 32249193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(17):1-121. PubMed ID: 23074487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis.
    Jiang YL; Qian LJ
    BMC Urol; 2019 Jan; 19(1):11. PubMed ID: 30691478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates.
    Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H
    BJU Int; 2016 Jan; 117(1):155-64. PubMed ID: 25851432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia.
    Radwan A; Farouk A; Higazy A; Samir YR; Tawfeek AM; Gamal MA
    Prostate Int; 2020 Sep; 8(3):130-133. PubMed ID: 33102395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety of prostatic urethral lift vs prostatic artery embolization for benign prostatic hyperplasia: a systematic review and network meta-analysis.
    Lucas-Cava V; Sánchez-Margallo FM; Insausti-Gorbea I; Sun F
    BJU Int; 2023 Feb; 131(2):139-152. PubMed ID: 35417622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.